GABRIEL MARTINEZ: Open Payments
NPI 1962603340 · FT. MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,773 in 72 payments from 8 companies in 2025. Trend: 2023 $1,183 · 2024 $1,604 · 2025 $1,773
Food & beverage: $1,773
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 15 | $432 |
| Janssen Pharmaceuticals, Inc | 14 | $295 |
| Alkermes, Inc. | 11 | $273 |
| E.R. Squibb & Sons, L.L.C. | 11 | $271 |
| Otsuka America Pharmaceutical, Inc. | 11 | $245 |
| Luye Pharma (USA) Ltd. | 8 | $195 |
| Indivior Inc. | 1 | $36 |
| ABBVIE INC. | 1 | $26 |
Products named: INVEGA SUSTENNA, ARISTADA, COBENFY, AUSTEDO XR, UZEDY, ERZOFRI EXTENDED-RELEASE, ABILIFY MAINTENA, ABILIFY ASIMTUFII.
Industry payments across FL — which companies pay providers there.
